Live Markets
Wednesday, July 29, 2026·George Town, KY·29°·Partly Cloudy
Markets Open · NYSE·Newsletter·Masthead·
VOL. XII · NO. 117Established MMXIV · George Town, Grand CaymanAtlantic Edition · $4.50

The Cayman Journal

Finance · Business · Technology · Caribbean & Global Affairs
Markets · Healthcare

Zomedica Corp. (ZOMDF)

OQB · Medical Devices

$0.08-0.01 (-7.76%)Quote refreshed

Sources: Yahoo Finance (quote, statistics) · SEC EDGAR (filings, insider trades, 13F holders) · company filings & press wires

Market Cap
$80.4M
P/E (TTM)
EPS
$-0.01
Div Yield
52W Range
$0.04–$0.16
Beta
1.35

Company overview

Next earnings: 2026-08-06(9d)

Zomedica Corp., a veterinary health company, focuses on the unmet needs of clinical veterinarians by developing products for companion animals. It offers diagnostic products comprising TRUFORMA Bulk Acoustic Wave point of care diagnostic platform; TRUVIEW, a digital cystoscopy platform that offers automated slide preparation within the instrument; and VetGuardian, a zero-touch vital signs remote monitoring system. The company provides therapeutic products, including PulseVet electrohydraulic shockwave therapy platform; and Assisi Loop line of products, including the Assisi Loop, Assisi Loop Lounge, Assisi EquiLoop, and DentaLoop devices that treat pain and inflammation through delivery of targeted pulsed electromagnetic field focused energy. The company was formerly known as Zomedica Pharmaceuticals Corp. and changed its name to Zomedica Corp. in October 2020. Zomedica Corp. is headquartered in Ann Arbor, Michigan.

141 employeeswww.zomedica.com

Peers in Healthcare

Zomedica Corp. has no peer companies in this window.

Recent press releases

Zomedica Corp. has not issued a press release in this window.

SEC filings

All filings →

Zomedica Corp. has not filed an SEC document in this window.

Zomedica Corp. has no reported insider trades in the last 90 days.

Institutional holders

All holders →
As of 2025-12-31 · prior 2025-09-30

People at Zomedica Corp.

All people →

Quarterly financials

Full financials →
Revenue trend
03/25
$4.5M
NI -$63.8M
06/25
$1.4M
NI -$7.4M
09/25
$8.1M
NI -$6.1M
RevenueNI = Net Income
EPS trend (diluted)
Latest: $-0.01
Prior: $-0.01
Revenue sparkline